AARDEX Group

MEMS Adherence Monitoring System chosen for trials of HIV-prevention medication in Africa and India

mems_system
DEC-2014 : Grant from The Bill & Melinda Gates Foundation to improve adherence

DEC-2014 : Grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials

MWV’s MEMS® System chosen for trials of HIV-prevention medication in Africa and India.

Global packaging company has received a grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials

Share This Post

You may also like...

Breaking News

Enhancing Medication Adherence in Rare Disease Clinical Trials

In observance of Rare Disease Day, it is imperative to underscore the progressive strides within the domain of rare disease research. Rare diseases, characterized by their infrequent occurrence within the general populace, impose significant burdens not only on the affected